Recent advancements in artificial intelligence for breast cancer: Image augmentation, segmentation, diagnosis, and prognosis approaches

J Zhang, J Wu, XS Zhou, F Shi, D Shen - Seminars in Cancer Biology, 2023 - Elsevier
Breast cancer is a significant global health burden, with increasing morbidity and mortality
worldwide. Early screening and accurate diagnosis are crucial for improving prognosis …

Deep learning in breast cancer imaging: A decade of progress and future directions

L Luo, X Wang, Y Lin, X Ma, A Tan… - IEEE Reviews in …, 2024 - ieeexplore.ieee.org
Breast cancer has reached the highest incidence rate worldwide among all malignancies
since 2020. Breast imaging plays a significant role in early diagnosis and intervention to …

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter …

YH Huang, T Zhu, XL Zhang, W Li, XX Zheng… - …, 2023 - thelancet.com
Background Accurate identification of pCR to neoadjuvant chemotherapy (NAC) is essential
for determining appropriate surgery strategy and guiding resection extent in breast cancer …

Development and validation of a radiopathomic model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer patients

J Zhang, Q Wu, W Yin, L Yang, B Xiao, J Wang, X Yao - BMC cancer, 2023 - Springer
Background Neoadjuvant chemotherapy (NAC) has become the standard therapeutic option
for early high-risk and locally advanced breast cancer. However, response rates to NAC vary …

Pretreatment ultrasound-based deep learning radiomics model for the early prediction of pathologic response to neoadjuvant chemotherapy in breast cancer

FH Yu, SM Miao, CY Li, J Hang, J Deng, XH Ye… - European Radiology, 2023 - Springer
Objectives To investigate the predictive performance of the deep learning radiomics (DLR)
model integrating pretreatment ultrasound imaging features and clinical characteristics for …

Cross-modal deep learning model for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer

J Guo, B Chen, H Cao, Q Dai, L Qin, J Zhang… - NPJ Precision …, 2024 - nature.com
Pathological complete response (pCR) serves as a critical measure of the success of
neoadjuvant chemotherapy (NAC) in breast cancer, directly influencing subsequent …

Automated and reusable deep learning (AutoRDL) framework for predicting response to neoadjuvant chemotherapy and axillary lymph node metastasis in breast …

J You, Y Huang, L Ouyang, X Zhang, P Chen… - …, 2024 - thelancet.com
Background Previous deep learning models have been proposed to predict the pathological
complete response (pCR) and axillary lymph node metastasis (ALNM) in breast cancer. Yet …

Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review

B Elsayed, A Alksas, M Shehata, A Mahmoud, M Zaky… - Cancers, 2023 - mdpi.com
Simple Summary Breast cancer is considered as the most common malignancy among
females, and its treatment takes many forms and types. Neoadjuvant chemotherapy (NACT) …

Artificial intelligence-assisted ultrasound image analysis to discriminate early breast cancer in Chinese population: a retrospective, multicentre, cohort study

J Liao, Y Gui, Z Li, Z Deng, X Han, H Tian, L Cai… - …, 2023 - thelancet.com
Background Early diagnosis of breast cancer has always been a difficult clinical challenge.
We developed a deep-learning model EDL-BC to discriminate early breast cancer with …

Early Identification of Pathologic Complete Response to Neoadjuvant Chemotherapy Using Multiphase DCE‐MRI by Siamese Network in Breast Cancer: A …

Y Huang, Y Cao, X Hu, X Lan, H Chen… - Journal of Magnetic …, 2024 - Wiley Online Library
Background Siamese network (SN) using longitudinal DCE‐MRI for pathologic complete
response (pCR) identification lack a unified approach to phases selection. Purpose To …